nalidixic acid has been researched along with norfloxacin in 321 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 211 (65.73) | 18.7374 |
| 1990's | 29 (9.03) | 18.2507 |
| 2000's | 55 (17.13) | 29.6817 |
| 2010's | 23 (7.17) | 24.3611 |
| 2020's | 3 (0.93) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, Y; Jinbo, Y; Kawahata, Y; Kondo, H; Sakamoto, F; Taguchi, M; Tsukamoto, G | 1 |
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Irikura, T; Itoh, A; Koga, H; Murayama, S; Suzue, S | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Bachand, B; Barnes, MH; Bethell, R; Brown, NC; Butler, MM; Cadilhac, C; Charron, S; Comstock, J; Dix, EJ; Foster, KA; Holm, KA; LaMarr, WA; Lamothe, S; Long, ZY; Manikowski, A; Motorina, I; Storer, R; Tarantino, PM; Wright, GE; Xu, WC; Zhi, C | 1 |
| Drlica, K; Hussain, S; Malik, M | 1 |
| Catalan, A; de la Campa, AG; Dominguez, L; Escudero, JA; Gonzalez-Zorn, B; Lopez, G; Moreno, MA; Rivero, E; San Millan, A | 1 |
| Levy, SB; Nicoloff, H; Perreten, V | 1 |
| Cattoir, V; Mazel, D; Nordmann, P; Poirel, L; Soussy, CJ | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 2 |
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Chevalier, J; Dupont, M; James, CE; Pagès, JM | 1 |
| Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Brazas, MD; Breidenstein, EB; Hancock, RE; Overhage, J | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Jones, GL; Stickler, DJ | 1 |
| Arakawa, Y; Chen, L; Chen, ZL; Deng, YT; Gao, JH; Liu, JH; Zeng, ZL | 1 |
| Alba, V; Alcalde, E; Blasco, MD; Esteve, C; Marti, S; Sánchez-Céspedes, J; Vila, J | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Espinal, P; Nordmann, P; Poirel, L; Silva-Sanchez, J | 1 |
| Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Ono, Y; Sasaki, T; Shimizu, K; Takahashi, N | 2 |
| Bailey, AM; Paulsen, IT; Piddock, LJ | 1 |
| Bremont, S; Charavay, F; Courvalin, P; Goarant, C; Le Hello, S; O'Connor, O; Page, S; Vernel-Pauillac, F | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Aarestrup, FM; Cavaco, LM; Hasman, H; Xia, S | 1 |
| Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH | 1 |
| Dionisi, AM; Lucarelli, C; Luzzi, I; Owczarek, S; Villa, L | 1 |
| Espinal, P; Gibert, I; Marti, S; Martínez, P; Roca, I; Vila, J | 1 |
| Caddick, JM; Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Lilly, AJ; Piddock, LJ; Siitonen, A; Webber, MA | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Bartalesi, F; Bartoloni, A; Gotuzzo, E; Mantella, A; Pallecchi, L; Riccobono, E; Rossolini, GM; Sennati, S; Trigoso, C | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Ahn, JH; Bae, IK; Lee, JE; Lee, JJ; Lee, SH; Park, I; Park, KS; Sun, HI; Woo, GJ | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Girgis, AS; Hall, CD; Katritzky, AR; Liaqat, S; Panda, SS; Samir, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
| Rahal, K | 1 |
| Bhattacharya, MK; Bhattacharya, SK; Debnath, A; Dutta, D; Dutta, P; Nag, A; Nair, GB; Pal, SC; Paul, M; Sen, D | 1 |
| Hoshino, K; Saiki, A; Sawai, T; Yamaguchi, A | 1 |
| Gootz, TD; Martin, BA | 1 |
| Agen, C; Blandizzi, C; De Bona, M; Del Tacca, M; Natale, G | 1 |
| Bhattacharya, MK; Bhattacharya, SK; Dutta, P; Moitra, A; Pal, SC; Rasaily, R; Sen, D | 1 |
| Adler-Mosca, H; Altwegg, M; Burnens, A; Lüthy-Hottenstein, J; Martinetti Lucchini, G | 1 |
| Barry, AL; Fuchs, PC | 1 |
| Acar, JF; Collatz, E; Guibert, J; Gutmann, L; Moniot-Ville, N; Moreau, N | 1 |
| Bhan, MK; Khoshoo, V; Raj, P; Srivastava, R | 1 |
| Aijima, H; Ishida, R; Kusajima, H; Machida, M; Maeda, A; Uchida, H | 1 |
| Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
| Lewin, CS; Smith, JT | 1 |
| Adair, CG; Casabar, E; Kasik, JE; Lettieri, J; Prince, RA; Wexler, DB | 1 |
| Focht, J; Klietmann, W; Nösner, K | 1 |
| Aoyama, H; Fujii, T; Fujimaki, K; Inoue, M; Mitsuhashi, S; Sato, K | 1 |
| Pedrini, AM; Tornaletti, S | 1 |
| Biasolo, MA; Faggionato, O; Ferrazzi, E; Palù, G; Peracchi, M; Stefanelli, S | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Cunningham, E; McGinnis, E; Parham, C | 1 |
| Björnegård, B; Brorson, JE; Trollfors, B; Zackrisson, G | 1 |
| Santos Ferreira, M; Vital, J | 1 |
| Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Guimaraes, MA; Noone, P | 1 |
| Geitz, JN; Lerk, CF; Tarko-Smit, NJ; Van Saene, HK; Van Saene, JJ | 1 |
| Newsom, SW | 2 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Avesani, V; Delmee, M | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Barba, D; Esposito, S; Galante, D; Pennucci, C | 2 |
| Baltch, AL; Bassey, CM; Smith, RP | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Andrews, JM; Diver, JM; Piddock, LJ; Wise, R | 1 |
| Pernet, AG; Shen, LL | 1 |
| Grimm, H | 2 |
| Hopfinger, AJ | 1 |
| Høiby, N | 1 |
| Hooper, DC; Ng, EY; Swartz, MN; Wolfson, JS | 1 |
| Forsgren, A; Striby, AC | 1 |
| Cellini, L; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
| Baldinelli, L; De Santis, S; De Simone, C; Ferrazzi, M; Pugnaloni, L; Sorice, F | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Kubesch, P; Tümmler, B; Wehsling, M | 1 |
| Kresken, M; Wiedemann, B | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Traub, WH | 2 |
| Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
| Cowlishaw, A; Eley, A; Greenwood, D; Slater, G; Teoh-Chan, CH | 1 |
| Bischoff, W | 1 |
| Schaeffer, AJ; Sisney, GA | 1 |
| Gadebusch, HH; Shungu, DL; Tutlane, VK; Weinberg, E | 1 |
| de Moor, G; Lacroix, G; Mambour, A; Rossion, N; Schuyteneer, F; van der Auwera, P | 1 |
| Forsgren, A | 1 |
| Esko, E; Renkonen, OV | 1 |
| Hoagland, VL; Sabbaj, J; Shih, WJ | 1 |
| Butzler, JP; Coignau, H; De Mol, P; Ghysels, G; Goossens, H; Grados, O; Innocent, H; Levy, J | 1 |
| Alpert, ML; Ginsberg, BP; Goldstein, EJ | 1 |
| Modde, H | 1 |
| Borsa, F; Humbert, G | 1 |
| Hill, S; Morgan, JR; Pathy, J; Yeates, M | 1 |
| Bailey, J; Heppleston, C; Richmond, S | 1 |
| Montay, G; Tassel, JP | 1 |
| Andremont, AO; Pecquet, SS; Tancrède, CH | 1 |
| De Vries-Hospers, HG; Van der Waaij, D; Welling, GW | 1 |
| Toorop-Bouma, AG; Van der Waaij, D | 1 |
| Verbist, L | 1 |
| Oliva, B; Ravagnan, G; Renzini, G; Selan, L | 1 |
| Brun, Y; Coulet, M; Fleurette, J; Forey, F | 1 |
| Pilliot, J; Ronco, E | 1 |
| Dabernat, H; Delmas, C; Lareng, MB | 1 |
| Daguet, GL; Delisle-Mizon, F; Lesage, D; Vergez, P | 1 |
| Bergogne-Berezin, E; Joly-Guillou, ML | 1 |
| Bryskier, A; Devos, J; Dubreuil, L; Romond, C | 1 |
| Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
| Petrou, MA; Rogers, TR | 1 |
| de la Rosa, EJ; de Pedro, MA; García-del Portillo, F; Pisabarro, AG | 1 |
| Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
| Walker, RC; Wright, AJ | 1 |
| King, A; Phillips, I | 1 |
| Caccamo, F; Nicoletti, G; Nicolosi, VM; Speciale, A; Stefani, S | 1 |
| Wolff, M | 1 |
| Habiyaremye, I; Lemmens, P; Ott, D; Rogerie, F; Vandepitte, J; Verbist, L | 1 |
| Smith, JT | 3 |
| Elliott, TS; Greenwood, D; Shelton, A | 1 |
| Gau, W; Petersen, U; Ploschke, HJ; Zeiler, HJ | 1 |
| Coll, R; Esteve, M; Moros, M; Parés, J; Xicota, MA | 1 |
| Georgiopoulos, AN; Karachalios, GN | 1 |
| Altwegg, M; Burnens, A; Penner, JL; Zollinger-Iten, J | 1 |
| Andremont, A; Pecquet, S; Tancrède, C | 1 |
| Neu, HC | 1 |
| Bryskier, A; Husson, MO; Izard, D; Leclerc, H | 1 |
| Bryskier, A; Chantot, JF | 1 |
| Bryskier, A; Croize, J; Le Noc, P; Robert, J | 1 |
| Drusano, GL; Morris, JG; Tenney, JH | 1 |
| Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
| Greenwood, D; Laverick, A | 1 |
| Bologna, M; Forchetti, CM; Martini, E; Vaggi, L | 1 |
| Crumplin, GC; Hirst, T; Kenwright, M | 1 |
| Bauer, D; Häberle, R; Traub, WH | 1 |
| King, A; Phillips, I; Shannon, K; Warren, C | 1 |
| Andriole, VT; Downs, J; Ryan, JL | 1 |
| Boppana, VK; Swanson, BN | 1 |
| Gruninger, RP; Khan, MY; Klicker, RE; Nelson, SM | 1 |
| Amphlett, M; Matthews, J; Newsom, SW; Warren, RE | 1 |
| Labthavikul, P; Neu, HC | 1 |
| Imai, J; Irikura, T; Kusajima, H; Morikawa, H; Uchida, H; Yuasa, R | 1 |
| Peddie, BA | 1 |
| Baba, S; Murai, K | 1 |
| Hadley, WK; Ohm-Smith, MJ; Sweet, RL | 1 |
| Irikura, T; Kusajima, H; Shimada, J; Uchida, H; Ueda, Y; Yamaji, T | 1 |
| Jonsson, M; Norrby, SR | 1 |
| Chippendale, GR; Maack, RW; Tenney, JH | 1 |
| Gadebusch, HH; Shungu, DL; Weinberg, E | 3 |
| Blain, Y; Le Hir, A; Montay, G; Roquet, F | 1 |
| Boppana, VK; Ferguson, RK; Rotmensch, HH; Swanson, BN; Vlasses, PH | 1 |
| Tenney, JH; Warren, JW | 1 |
| Norrby, SR; Rylander, M | 1 |
| Cherubin, CE; Corrado, ML; Shulman, M | 1 |
| Bailey, RR; Blake, E; Peddie, BA | 1 |
| Andrews, JM; Edwards, LJ; Wise, R | 1 |
| Bauernfeind, A; Petermüller, C | 1 |
| Bailey, RR; Kirk, JA; Peddie, BA | 1 |
| Jensen, KM; Madsen, PO | 1 |
| Chartrand, SA; Marks, MI; Scribner, RK; Weber, AH; Welch, DF | 1 |
| Kashimoto, S; Katae, H; Minami, A; Nakamura, S; Nakata, K; Shimizu, M; Takase, Y; Yamagishi, J | 1 |
| Bebear, C; Cantet, P; Quentin, C; Renaudin, H | 1 |
| Norrby, SR | 1 |
| Body, BA; Fromtling, RA; Shadomy, HJ; Shadomy, S | 1 |
| Haase, D; Harding, G; Ronald, A; Urias, B | 1 |
| Shadomy, S; Wood, SJ | 1 |
| Bland, J; Edison, A; Huber, J | 1 |
| Di Nola, F; Eandi, M; Genazzani, E; Leone, L; Viano, I | 1 |
| Antunez de Mayolo, E; Benavente, L; Falconi, E; Guerra, JG; Palomino, JC | 1 |
| Daikos, GK; Giamarellou, H; Petrikkos, G; Tsagarakis, J | 1 |
| Machka, K; Vogelsang, G | 1 |
| Meier-Ewert, H; Millott, G; Weil, G | 1 |
| Ottrad, M; Shah, PM; Stille, W | 1 |
| Bassler, M; Bosbach, U; Daschner, F | 1 |
| Panichi, G; Pantosti, A; Testore, GP | 1 |
| Kashimoto, S; Kurobe, N; Nakamura, S; Ohue, T; Shimizu, M; Takase, Y | 1 |
| Inoue, M; Kouno, K; Mitsuhashi, S | 1 |
| Smith, T; Spencer, RC; Wheat, P | 1 |
| Gadebusch, HH; Shungu, DL; Tutlane, V | 1 |
| Muytjens, HL; van der Ros-van de Repe, J; van Veldhuizen, G | 1 |
| Lindner, U; Simon, C | 1 |
| Frimodt-Møller, PC; Jensen, KM; Madsen, PO | 1 |
| Fass, RJ | 1 |
| Forward, KR; Gray, GJ; Harding, GK; Ronald, AR; Urias, BA | 1 |
| Arini, A; Peduzzi, R; Piffaretti, JC | 1 |
| Chin, NX; Neu, HC | 2 |
| Bayne, WF; Musson, DG; Pauliukonis, LT | 1 |
| Currie, WJ; Deaney, NB; Vandenburg, MJ; Vogel, R | 1 |
| Vuye, A | 1 |
| Klesel, N; Limbert, M; Seibert, G | 1 |
| Demarta, A; Leidi-Bulla, L; Peduzzi, R; Piffaretti, JC | 1 |
| Adhami, ZN; Crump, B; Weston, D; Wise, R | 1 |
| Heessen, FW; Muytjens, HL | 1 |
| Ottnad-Walz, M; Shah, PM; Stille, W | 1 |
| Barry, AL; Jones, RN | 2 |
| Appleman, MD; Corigliano, BE; Heseltine, PN; Leedom, JM | 1 |
| Cowlishaw, WA; Goodwin, J; Greenwood, D; Osman, M; Slack, R | 1 |
| King, A; Phillips, I; Shannon, K | 1 |
| Bywater, MJ; Holt, HA; Reeves, DS; White, LO | 1 |
| Dibb, WL; Digranes, A; Ostervold, B | 1 |
| Ayers, LW; Barry, AL; Gerlach, EH; Jones, RN; Sommers, HM; Thornsberry, C | 1 |
| Kirby, CP | 1 |
| Currie, WJ; Deaney, NB; Round, EM; VandenBurg, MJ; Vogel, R | 1 |
| Duckworth, GJ; Williams, JD | 1 |
| Greenwood, D | 1 |
| Howson, GL; Lacey, RW; Lord, VL | 1 |
| Asscher, AW; Hughes, PJ; Webb, DB | 1 |
| Wise, R | 1 |
| Bendall, MJ | 1 |
| Leigh, DA; Marriner, J; Smith, EC | 1 |
| Emmanuel, FX; Leigh, DA | 1 |
| Chait, I; Deaney, NB; Kelsey, MC; Newsom, RA; Newsom, SW; Round, EM; Smith, J; Toase, PD; Vogel, R; Watt, B | 1 |
| Bint, AJ; Lacey, RW; Mahendra, M; Mummery, RV; Newsom, SW; Reeves, DS | 1 |
| Berg, SW; Colby, SD; Crider, SR; Harrison, WO; Kerbs, SB; Miller, LK | 1 |
| Cofsky, RD; duBouchet, L; Landesman, SH | 1 |
| DeYoung, DR; Gay, JD; Roberts, GD | 1 |
| Bologna, M; Carlucci, G; Cavicchio, G; Flammini, D; Forchetti, C; Vaggi, L | 1 |
| Bland, JA; Gadebusch, HH; Gilfillan, EC; Malatesta, PF; Pelak, BA | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Grohe, K; Zeiler, HJ | 1 |
| Gabriel, FG; Mumtaz, G; Oriel, JD; Ridgway, GL | 1 |
| Diez-Enciso, M; Gutierrez-Altes, A; Mas-Jimenez, G; Velasco-Cerrudo, A | 1 |
| Machka, K | 1 |
| Balg, H; Machka, K | 1 |
| García-Rodríguez, JA; Gómez-García, AC; Rodrigo, N | 1 |
| Fillastre, JP; Hannedouche, T; Humbert, G; Leroy, A | 1 |
| Bauernfeind, A; Ullmann, U | 1 |
| Adhami, ZN; Lockley, R; Webberly, M; Wise, R | 1 |
| Haase, DA; Harding, GK; Kennedy, JK; Ronald, AR; Thomson, MJ; Urias, BA | 1 |
| Peeters, M; Piot, P; Van Dyck, E | 1 |
| Dørflinger, T; Frimodt-Møller, PC; Madsen, PO | 1 |
| Allocati, N; Catamo, G; Piccolomini, R | 1 |
| Barba, D; Esposito, S; Galante, D; Limauro, D; Pennucci, C; Scioli, C | 1 |
| Abruzzo, GK; Fromtling, RA; Gadebusch, HH | 2 |
| Husson, MO; Izard, D; Leclerc, H | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
| Darrell, RW; Fox, CL; Modak, SM | 1 |
| Hirai, K; Inoue, M; Irikura, T; Ito, A; Koga, H; Mitsuhashi, S; Suzue, S | 1 |
| Abe, Y; Hirai, K; Inoue, M; Irikura, T; Ito, A; Mitsuhashi, S; Suzue, S | 1 |
| Fox, CL; Modak, SM | 1 |
| Gruninger, RP; Khan, MY; Siddiqui, Y | 1 |
| Chung, SK; Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
| Howard, BM; Pinney, RJ; Smith, JT | 2 |
| Mamet, R; Schoenfeld, N | 1 |
| Ichikawa, N; Iwamoto, K; Naora, K | 1 |
| Phillips, I; Power, EG | 1 |
| Ferguson, J; Johnson, BE | 1 |
| Dai, J; Meatherall, R | 1 |
| Chen, CH; Chiang, HY; Lee, F; Lee, JH; Lee, SH; Liu, YT; Tsou, TL; Wang, TM | 1 |
| Churilla, AM; el-Etr, SH; Gabriel, ME; Ismail, TF; Oyofo, BA; Peruski, LF; Petruccelli, BP; Wasfy, MO | 1 |
| Deguchi, T; Kawada, Y; Kawamura, T; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
| Badrinath, S; Rao, RS; Vijayalakshmi, N | 1 |
| Adolphe, M; Bernard-Beaubois, K; Hayem, G; Hecquet, C; Rat, P | 1 |
| Chignell, CF; Martínez, L | 1 |
| Akagi, M; Fukuishi, N; Kanoh, R; Matsui, N | 1 |
| Gillette, WK; Martin, RG; Rosner, JL | 1 |
| Drlica, K; Fournier, B; Hooper, DC; Lu, T; Zhao, X | 1 |
| Cahen, P; Honderlick, P | 1 |
| Chuma, T; Ikeda, T; Maeda, T; Niwa, H; Okamoto, K | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Janicka, G; Kłyszejko, C; Sekowska, A; Szymankiewicz, M; Wojda, M; Wróblewski, M | 1 |
| Benedí, VJ; Conejo, Mdel C; Doménech-Sánchez, A; García, I; Joyanes, P; Martínez-Martínez, L; Pascual, A | 1 |
| Balaji, V; Jesudason, MV; Thomson, CJ | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Chuma, T; Maeda, T; Niwa, H; Okamoto, K | 1 |
| Amicosante, G; Becerro, P; Casañas, L; Jiménez de Anta, MT; Perilli, M; Tavío, MM; Vila, J | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Hari, AC; Kibbey, TC; Paruchuri, RA; Sabatini, DA | 1 |
| Abba, M; Donnelly, J; Hussain, B; Shervington, LA | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Intravijit, J; Kibbey, TC; Lorphensri, O; Osathaphan, K; Sabatini, DA; Saiwan, C | 1 |
| Itoh, T; Mitsumori, K; Moto, M; Sakai, H; Takahashi, M | 1 |
| Begic, S; Worobec, EA | 1 |
| Dalla Costa, LM; Gales, AC; Ito, CA; Munerato, P; Tognim, MC | 1 |
| Adam, E; Baitiche, M; Chevalier, J; Mahamoud, A; Pagès, JM | 1 |
| Calhoun, LN; Kwon, YM | 1 |
| Bareja, E; Chróst, A; Gierczyński, R; Januszkiewicz, A; Olak, M; Piekarska, K; Rzeczkowska, M; Zacharczuk, K | 1 |
| Carson, L; Irwin, NJ; McCoy, CP | 1 |
| Botello, E; García-Cañas, A; González-Soltero, R; Mendoza-Chamizo, B; Mohedano, RB | 1 |
| Changkaew, K; Changkwanyeun, R; Kongsoi, S; Nakajima, C; Pornruangwong, S; Siripanichgon, K; Suthienkul, O; Suzuki, Y; Tamura, Y; Tsunoda, R; Utrarachkij, F | 1 |
| Bao, CJ; Gu, B; Kong, XX; Li, J; Liu, GY; Ma, P; Qian, HM; Qin, TT | 1 |
| Al-Maary, KS; Alwarhi, WK; El-Hariri, MD; Eljakee, JK; Ghareeb, A; Hemeg, HA; Hussein, HA; Kabli, SA; Magdy, OS; Moussa, IM; Mubarak, AS | 1 |
| Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA | 1 |
| Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
9 review(s) available for nalidixic acid and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Quinolone antibiotics.
Topics: | 2019 |
Computer-assisted drug design.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Chemistry; Computers; DNA; Drug Industry; Folic Acid Antagonists; Models, Molecular; Molecular Conformation; Nalidixic Acid; Naphthacenes; Norfloxacin; Patents as Topic; Receptors, Drug; Structure-Activity Relationship; Technology, Pharmaceutical | 1985 |
Mechanisms of action of and resistance to ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Mutation; Nalidixic Acid; Norfloxacin; Topoisomerase II Inhibitors | 1987 |
Symposium on antimicrobial agents. The quinolones.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Humans; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
The mode of action of 4-quinolones and possible mechanisms of resistance.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1986 |
Norfloxacin--a review of pharmacology and tissue penetration.
Topics: Animals; Anti-Infective Agents, Urinary; Biotransformation; Humans; Injections, Intravenous; Intestinal Absorption; Kinetics; Liver; Nalidixic Acid; Norfloxacin; Tissue Distribution | 1984 |
A review of urinary tract infection in the elderly.
Topics: Aged; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacterial; Furazolidone; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Norfloxacin; Novobiocin; Rifampin; Vibrio cholerae; Virulence Factors | 2022 |
18 trial(s) available for nalidixic acid and norfloxacin
| Article | Year |
|---|---|
Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Topics: Adult; Double-Blind Method; Dysentery, Bacillary; Humans; Male; Nalidixic Acid; Norfloxacin; Shigella | 1992 |
Randomized clinical trial of norfloxacin for shigellosis.
Topics: Adult; Dysentery, Bacillary; Humans; Nalidixic Acid; Norfloxacin | 1991 |
Effect of quinolone antimicrobials on theophylline pharmacokinetics.
Topics: Adult; Ciprofloxacin; Half-Life; Humans; Male; Metabolic Clearance Rate; Nalidixic Acid; Norfloxacin; Random Allocation; Theophylline | 1989 |
Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
Topics: Adult; Anal Canal; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vagina | 1985 |
Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
Topics: Adult; Bacteria; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
Topics: Adult; Drug Combinations; Female; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
A controlled trial of norfloxacin and amoxycillin in the treatment of uncomplicated urinary tract infection in the elderly.
Topics: Aged; Amoxicillin; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Humans; Middle Aged; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1985 |
Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
Topics: Adult; Aged; Bacterial Infections; Bacteriuria; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Prospective Studies; Random Allocation; Recurrence; Urinary Tract Infections | 1987 |
Norfloxacin disposition after sequentially increasing oral doses.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Crystallization; Half-Life; Humans; Male; Nalidixic Acid; Norfloxacin; Solubility | 1983 |
Potential usefulness of norfloxacin in the treatment of urinary tract infections.
Topics: Anti-Infective Agents; Clinical Trials as Topic; Humans; Nalidixic Acid; Norfloxacin; Tissue Distribution; Urinary Tract Infections | 1983 |
Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1983 |
Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1983 |
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Bacteria; Drug Administration Schedule; Drug Combinations; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
Topics: Aged; Amoxicillin; Anti-Infective Agents, Urinary; Cinoxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1984 |
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents, Urinary; Citrates; Citric Acid; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Random Allocation; Urinary Tract Infections | 1984 |
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Feces; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urethra; Urinary Tract Infections | 1984 |
Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic.
Topics: Adolescent; Adult; Candida albicans; DNA; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemolysis; Histidine; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Photosensitivity Disorders; Ultraviolet Rays | 1993 |
294 other study(ies) available for nalidixic acid and norfloxacin
| Article | Year |
|---|---|
Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.
Topics: Animals; Anti-Infective Agents; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 1992 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.
Topics: Anti-Bacterial Agents; Bacteria; Quinolines; Structure-Activity Relationship | 1980 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; DNA Polymerase III; Drug Resistance, Bacterial; Gram-Positive Bacteria; Male; Mice; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors; Toxicity Tests, Acute; Uracil | 2006 |
Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; DNA Fragmentation; DNA Gyrase; DNA, Bacterial; DnaB Helicases; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Models, Biological; Molecular Structure; Nalidixic Acid; Quinolones | 2007 |
First characterization of fluoroquinolone resistance in Streptococcus suis.
Topics: Amino Acid Sequence; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Molecular Sequence Data; Point Mutation; RNA, Ribosomal, 16S; Sequence Alignment; Streptococcus suis | 2007 |
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Amplification; Genome, Bacterial; Genomic Instability; Multidrug Resistance-Associated Proteins; Mutation; Protease La | 2007 |
Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Computer Simulation; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Amplification Techniques; Open Reading Frames; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Vibrio | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Plasmid-mediated quinolone resistance determinant QnrB4 identified in France in an Enterobacter cloacae clinical isolate coexpressing a QnrS1 determinant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia coli; France; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids; Quinolones; Transformation, Genetic | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Galactosidase; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Environment; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Genes, MDR; Hydrolases; Plasmids; Pore Forming Cytotoxic Proteins; Porins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2007 |
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Heat-Shock Proteins; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Protease La; Pseudomonas aeruginosa | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Methyltransferases; Plasmids; RNA, Ribosomal, 16S; Swine; Swine Diseases | 2008 |
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.
Topics: Aeromonas; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plasmids; Quinolones | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli.
Topics: Base Sequence; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Quinolones | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Molecular Sequence Data; Sequence Homology, Amino Acid; Stenotrophomonas maltophilia | 2008 |
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Bacterial Proteins; Base Sequence; Chlorpromazine; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Gene Expression; Genes, Bacterial; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenothiazines; Salmonella typhimurium; Trans-Activators | 2008 |
Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.
Topics: Amino Acid Substitution; Base Sequence; DNA Gyrase; DNA Mutational Analysis; DNA Primers; DNA Probes; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Nucleic Acid Denaturation; Point Mutation; Polymerase Chain Reaction; Streptococcus pneumoniae; Thermodynamics | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cattle; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Quinolones; Salmonella enterica | 2009 |
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids | 2009 |
Emergence of quinolone-resistant Bordetella pertussis in Japan.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Child; DNA Gyrase; Fluoroquinolones; Humans; Japan; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2009 |
Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Microbial Sensitivity Tests; Multigene Family; Plasmids; Quinolones; Salmonella typhimurium | 2009 |
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol Resistance; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Tetracyclines | 2009 |
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Electroporation; Genotype; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella enterica | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Characterization of small ColE-like plasmids mediating widespread dissemination of the qnrB19 gene in commensal enterobacteria.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotype; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Quinolones | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Novel variants of the qnrB gene, qnrB22 and qnrB23, in Citrobacter werkmanii and Citrobacter freundii.
Topics: Animals; Bacterial Proteins; Chickens; Citrobacter; Citrobacter freundii; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Quinolones; Swine | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Species Specificity | 1992 |
OmpF channel permeability of quinolones and their comparison with beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Cell Membrane Permeability; Cephalosporins; Diffusion; Enoxacin; Escherichia coli; Liposomes; Nalidixic Acid; Norfloxacin; Ofloxacin; Stereoisomerism | 1992 |
Characterization of high-level quinolone resistance in Campylobacter jejuni.
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Quinolones; Topoisomerase II Inhibitors | 1991 |
Effects of quinolone carboxylic acid derivatives on GABAA receptor-mediated stimulation of gastric acid secretion and intestinal motility.
Topics: Acetylcholine; Animals; Deoxyglucose; Female; GABA-A Receptor Antagonists; Gastric Acid; Gastric Mucosa; Gastrointestinal Motility; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1991 |
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.
Topics: Adult; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Restriction Mapping | 1991 |
In vitro susceptibility testing procedures for fosfomycin tromethamine.
Topics: Bacteria; Fosfomycin; Glucose-6-Phosphate; Glucosephosphates; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
Topics: Anti-Infective Agents; DNA; Drug Resistance, Microbial; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1991 |
Salmonella typhimurium-associated severe protracted diarrhea in infants and young children.
Topics: Amikacin; Combined Modality Therapy; Diarrhea, Infantile; Failure to Thrive; Female; Fluid Therapy; Humans; India; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Prevalence; Salmonella Infections; Salmonella typhimurium | 1990 |
Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals.
Topics: Administration, Oral; Aging; Animals; Dogs; Dose-Response Relationship, Drug; Joint Diseases; Joints; Macaca fascicularis; Male; Nalidixic Acid; Norfloxacin; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1990 |
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype; Staphylococcus aureus | 1990 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
DNA breakdown by the 4-quinolones and its significance.
Topics: Ciprofloxacin; DNA, Bacterial; Escherichia coli; Nalidixic Acid; Norfloxacin; Rifampin; SOS Response, Genetics; Species Specificity; Time Factors | 1990 |
Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Nalidixic Acid; Norfloxacin; Pseudomonas; Topoisomerase II Inhibitors | 1987 |
Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.
Topics: Anti-Bacterial Agents; Citrobacter; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Nalidixic Acid; Norfloxacin; Quinolines; Topoisomerase II Inhibitors | 1988 |
Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.
Topics: Chloroquine; DNA, Circular; DNA, Superhelical; Nalidixic Acid; Norfloxacin; Nucleic Acid Conformation; Topoisomerase II Inhibitors | 1988 |
Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid.
Topics: Aminocoumarins; BK Virus; Chromatin; Coumarins; Deoxyribonuclease I; Nalidixic Acid; Norfloxacin; Simian virus 40; Topoisomerase II Inhibitors; Virus Replication | 1988 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Differential effects of DNA gyrase inhibitors on the genetic transformation of Neisseria gonorrhoeae.
Topics: Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Novobiocin; Topoisomerase II Inhibitors; Transformation, Bacterial | 1988 |
Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.
Topics: Amdinocillin; Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Doxycycline; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Rifampin; Thienamycins | 1985 |
The comparative in vitro activity of ofloxacin (RU 43 280) and other quinolone derivatives against 722 bacteria of clinical interest.
Topics: Bacteria; Bacteroides fragilis; Clostridium perfringens; Enterobacteriaceae; Fusobacterium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Structure-Activity Relationship | 1987 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
Topics: Acinetobacter; Bacteria; Bacterial Infections; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Quinolines; Serratia; Staphylococcus | 1986 |
Quinolones and colonization resistance in human volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Digestive System; Feces; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines | 1986 |
The clinical use of quinolones.
Topics: Ciprofloxacin; Escherichia coli; Feces; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Kinetics; Male; Micrococcus; Nalidixic Acid; Norfloxacin; Quinolines; Respiratory Tract Infections; Time Factors; Urologic Diseases | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Topics: Bacteriuria; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines | 1985 |
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines | 1986 |
In vitro evaluation of A-56619 and A-56620, two new quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines | 1986 |
In vitro studies of S-25930 and S-25932, two new 4-quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Edetic Acid; Enterobacteriaceae; Gram-Positive Bacteria; Humans; Kinetics; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines; Quinolizines | 1986 |
Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.
Topics: Binding, Competitive; Coliphages; DNA, Single-Stranded; DNA, Superhelical; DNA, Viral; Hydrogen-Ion Concentration; Kinetics; Nalidixic Acid; Norfloxacin; Osmolar Concentration; Plasmids; Topoisomerase II Inhibitors | 1985 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacin.
Topics: Drug Resistance, Microbial; Escherichia coli; Humans; Mutation; Nalidixic Acid; Norfloxacin | 1988 |
Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; R Factors | 1988 |
Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
Topics: Adult; Anti-Infective Agents; DNA; Humans; In Vitro Techniques; Interferon-gamma; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Piromidic Acid | 1986 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
Topics: Anti-Bacterial Agents; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Polymyxin B; Pseudomonas aeruginosa; Quinolines | 1987 |
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid; Quinolines; Serratia marcescens | 1985 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Drug Evaluation; Enoxacin; Humans; Hydrogen-Ion Concentration; Models, Biological; Nalidixic Acid; Naphthyridines; Norfloxacin; Urinary Bladder; Urinary Tract Infections | 1985 |
[Norfloxacin treatment of acute cystitis in the female and bacterial prostatitis].
Topics: Adult; Anti-Infective Agents, Urinary; Bacterial Infections; Cystitis; Female; Humans; Male; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Prostatitis; Recurrence | 1985 |
In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Eye Diseases; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1985 |
In vitro activity of enoxacin compared with norfloxacin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Calcium; Drug Interactions; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Kanamycin; Magnesium; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus | 1985 |
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefaclor; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillins; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Urinary Tract Infections | 1985 |
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Topics: Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Leucomycins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
[Norfloxacin sensitivity of bacterial pathogens of urinary tract infections].
Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1985 |
[Treatment of urinary tract infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Female; Humans; Lactams; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Prostatitis; Urinary Tract Infections | 1985 |
Antichlamydial activity of quinolone carboxylic acids.
Topics: Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Prostate | 1985 |
Selective decontamination of the digestive tract by norfloxacin. A preliminary report.
Topics: Anti-Bacterial Agents; Digestive System; Enterobacteriaceae; Feces; Humans; Nalidixic Acid; Norfloxacin | 1985 |
Norfloxacin for selective decontamination: a study in human volunteers.
Topics: Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Feces; Gram-Negative Bacteria; Humans; Male; Nalidixic Acid; Norfloxacin | 1985 |
The effect of selective decontamination of the gi-tract of mice on the survival of intestinal mucosa during X-irradiation.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Colon; Digestive System; Female; Gram-Negative Bacteria; Ileum; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Nalidixic Acid; Neomycin; Norfloxacin | 1985 |
Belgian multicenter in vitro study of norfloxacin.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urine | 1985 |
Inhibition of conjugal transfer by new quinolinic compounds.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Quinolines; Quinolones | 1985 |
Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines; Species Specificity; Urinary Tract Infections; Urine | 1985 |
[Influence of technical factors in the determination of minimal inhibitory concentration by microdilution].
Topics: Agar; Enterobacteriaceae; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
[Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Topics: Coagulase; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Penicillin Resistance; Staphylococcus; Staphylococcus aureus | 1985 |
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Streptococcus pneumoniae | 1985 |
[Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Topics: Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Pseudomonas; Pseudomonas aeruginosa; Quinolines | 1985 |
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1985 |
[Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Topics: Bacteria, Anaerobic; Bacteroides; Clostridium; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1985 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
In-vitro activity of antifungal agents in combination with four quinolones.
Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae | 1988 |
Modulation of cell wall synthesis by DNA replication in Escherichia coli during initiation of cell growth.
Topics: Bacterial Proteins; Carrier Proteins; Cefsulodin; Cell Division; Cell Wall; DNA Replication; DNA, Bacterial; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Nalidixic Acid; Norfloxacin; Penicillin-Binding Proteins; Peptidoglycan; Peptidyl Transferases; Rec A Recombinases; SOS Response, Genetics | 1987 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperacillin | 1987 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Topics: Adolescent; Adult; Dysentery, Bacillary; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Rwanda; Shigella dysenteriae | 1986 |
The response of Escherichia coli to ciprofloxacin and norfloxacin.
Topics: Cell Wall; Ciprofloxacin; Cytoplasm; Drug Resistance, Microbial; Escherichia coli; Microscopy, Electron; Microscopy, Electron, Scanning; Nalidixic Acid; Norfloxacin; Vacuoles | 1987 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
Topics: Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Structure-Activity Relationship | 1987 |
In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Quinolines | 1987 |
Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.
Topics: Adult; Bacterial Proteins; Campylobacter fetus; Campylobacter Infections; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1987 |
Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.
Topics: Animals; Anti-Infective Agents; Feces; Germ-Free Life; Humans; Intestines; Mice; Mice, Inbred C3H; Nalidixic Acid; Norfloxacin; Time Factors | 1986 |
The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones; Structure-Activity Relationship; Urinary Tract Infections | 1985 |
Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid | 1985 |
Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Blood Proteins; Drug Resistance, Microbial; Male; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding | 1985 |
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Topics: Acinetobacter; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas aeruginosa | 1985 |
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
Topics: Ampicillin; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio | 1985 |
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
Topics: Blood Bactericidal Activity; Ciprofloxacin; Culture Media; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Phagocytosis; Pipemidic Acid; Quinolines; Serratia marcescens; Topoisomerase II Inhibitors | 1984 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
Activities of newer quinolones against Legionella group organisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Legionella; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
Bactericidal intraprostatic concentrations of norfloxacin.
Topics: Anti-Infective Agents; Humans; Male; Nalidixic Acid; Norfloxacin; Prostate; Prostatitis | 1983 |
Investigations into the mechanism of action of the antibacterial agent norfloxacin.
Topics: Anti-Infective Agents, Urinary; Bacteria; Bacterial Proteins; Culture Media; DNA Topoisomerases, Type II; DNA, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; RNA, Bacterial | 1984 |
Characterization of two clinical, multiple-drug-resistant isolates of Enterobacter cloacae.
Topics: Adult; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacteriocins; Blood Bactericidal Activity; Cephalosporinase; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Enoxacin; Enterobacter; Enterobacteriaceae; Female; Humans; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; O Antigens; R Factors; Virulence | 1984 |
In vitro antibacterial activity of norfloxacin (MK-0366).
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Staphylococcus; Streptococcus | 1982 |
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa; Urinary Tract Infections | 1982 |
Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Male; Nalidixic Acid; Norfloxacin | 1982 |
Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1982 |
Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pyridones | 1982 |
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim | 1982 |
[Pharmaceutical studies on hydrates of AM-715. Physical characteristics and intestinal absorption].
Topics: Anhydrides; Animals; Anti-Infective Agents; Biological Availability; Chemical Phenomena; Chemistry, Physical; Dogs; Intestinal Absorption; Nalidixic Acid; Norfloxacin; Water | 1982 |
Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
Topics: Anti-Bacterial Agents; Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas | 1982 |
Studies on distribution of two nalidixic acid analogs in otorhinolaryngological field.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Otorhinolaryngologic Diseases; Palate, Soft; Pipemidic Acid; Rabbits; Radiometry; Tissue Distribution | 1982 |
Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
Topics: Anti-Infective Agents, Urinary; Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Urinary Tract; Urinary Tract Infections | 1982 |
Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
Topics: Adult; Animals; Anti-Infective Agents; Creatinine; Dogs; Humans; Kidney; Male; Metabolic Clearance Rate; Nalidixic Acid; Norfloxacin; Probenecid; Rabbits; Species Specificity | 1983 |
Antibacterial activity of norfloxacin.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1983 |
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1983 |
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Digestive System; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
High-performance liquid chromatography of pefloxacin and its main active metabolites in biological fluids.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Nalidixic Acid; Norfloxacin; Pefloxacin; Time Factors | 1983 |
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
Topics: Anti-Bacterial Agents; Bacteria; Diffusion; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Regression Analysis | 1983 |
Bactericidal activity of norfloxacin and nine other urinary tract antibiotics against Gram-negative bacilli causing bacteriuria in chronically catheterized patients.
Topics: Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Catheterization; Cinoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1983 |
Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Escherichia coli Infections; Klebsiella Infections; Nalidixic Acid; Norfloxacin; Rabbits | 1983 |
The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1983 |
Norfloxacin for the treatment of uncomplicated urinary tract infections.
Topics: Adult; Bacterial Infections; Drug Evaluation; Female; Humans; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1983 |
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Topics: Anti-Infective Agents, Urinary; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
Norfloxacin-induced rheumatic disease.
Topics: Adult; Anti-Infective Agents; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Tendinopathy | 1983 |
Distribution of quinoline carboxylic acid derivatives in the dog prostate.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Dogs; Drug Evaluation, Preclinical; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Prostatitis; Quinolines; Quinolones; Time Factors; Tissue Distribution; Urinary Tract Infections | 1983 |
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Stability; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas | 1983 |
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Enoxacin; Gentamicins; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Ureaplasma | 1983 |
In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Citrobacter; Drug Evaluation, Preclinical; Enterobacter; Escherichia coli; Humans; Klebsiella; Nalidixic Acid; Norfloxacin; Proteus; Pseudomonas; Salmonella; Serratia | 1983 |
Comparative in vitro activity of norfloxacin against urinary tract pathogens.
Topics: Anti-Bacterial Agents; Drug Evaluation, Preclinical; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Humans; Nalidixic Acid; Norfloxacin; Species Specificity; Structure-Activity Relationship; Urinary Tract Infections | 1983 |
Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteria.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Drug Evaluation, Preclinical; Humans; Nalidixic Acid; Norfloxacin | 1983 |
Criteria for interpretation of agar diffusion susceptibility tests of norfloxacin performed by the ICS method.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Drug Evaluation, Preclinical; Humans; Nalidixic Acid; Norfloxacin | 1983 |
Bioassay procedures for norfloxacin.
Topics: Anti-Bacterial Agents; Biological Assay; Humans; Klebsiella pneumoniae; Nalidixic Acid; Norfloxacin | 1983 |
Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.
Topics: Adult; Aged; Anti-Infective Agents; Female; Hepatitis B; Humans; Kidney Failure, Chronic; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Nalidixic Acid; Norfloxacin | 1983 |
In vitro activity of norfloxacin against multi-resistant bacteria.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1983 |
In vitro activity of norfloxacin against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Humans; Nalidixic Acid; Norfloxacin; Species Specificity; Urethritis | 1983 |
In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Pyridazines; Serratia marcescens | 1983 |
Effect of norfloxacin on Staphylococcus aureus and Pseudomonas aeruginosa in broth, serum and in combination with human polymorphonuclear leukocytes.
Topics: Anti-Bacterial Agents; Humans; Nalidixic Acid; Neutrophils; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1983 |
Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Humans; Middle Aged; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1983 |
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Autoradiography; Bile; Dogs; Enoxacin; Female; Kinetics; Macaca fascicularis; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1983 |
In vitro and in vivo antibacterial activity of AT-2266.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enoxacin; Male; Mice; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
Antibacterial activity of norfloxacin.
Topics: Bacteria; Drug Resistance, Microbial; Humans; Nalidixic Acid; Norfloxacin | 1983 |
Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacin.
Topics: Anti-Infective Agents; Bacteriological Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quality Control; Reference Standards | 1983 |
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Quinolines | 1983 |
In vitro activity of norfloxacin against Mycoplasma hominis and Ureaplasma urealyticum.
Topics: Mycoplasma; Nalidixic Acid; Norfloxacin; Ureaplasma | 1983 |
Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Digestive System; Drinking; Feces; Nalidixic Acid; Neomycin; Norfloxacin; Rats; Rats, Inbred Strains | 1983 |
In vitro activity of ciprofloxacin (Bay o 9867).
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1983 |
In vitro activity of norfloxacin against Neisseria gonorrhoeae.
Topics: Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin | 1983 |
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Colony-Forming Units Assay; Drug Resistance, Microbial; Drug Synergism; Enoxacin; Microbial Sensitivity Tests; Mutagens; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Trimethoprim | 1983 |
Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reverse-phase chromatography.
Topics: Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Humans; Hydrolysis; Male; Nalidixic Acid; Norfloxacin | 1984 |
Norfloxacin in acute urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacteriuria; Child; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1984 |
In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Topics: Anti-Bacterial Agents; Cinoxacin; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid | 1983 |
Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Drug Resistance, Microbial; Lactams; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid | 1983 |
In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
Topics: Drug Resistance, Microbial; Escherichia coli; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1983 |
The pharmacokinetics and tissue penetration of norfloxacin.
Topics: Adult; Anti-Infective Agents; Blister; Cantharidin; Exudates and Transudates; Half-Life; Humans; Kinetics; Male; Nalidixic Acid; Norfloxacin | 1984 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Cinoxacin; Ciprofloxacin; Humans; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Quinolines | 1984 |
In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Cinoxacin; Culture Media; Humans; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Pyridazines; Urine | 1983 |
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Topics: Acinetobacter; Anti-Infective Agents, Urinary; Bacteria; Cinoxacin; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pseudomonas; Pseudomonas aeruginosa; Quality Control; Reference Standards; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
Topics: Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Norfloxacin; Pseudomonas Infections; Serratia marcescens; Urinary Tract Infections | 1984 |
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Protein Binding; Quinolines | 1984 |
Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Escherichia coli; Humans; Hydrogen-Ion Concentration; Klebsiella pneumoniae; Models, Biological; Nalidixic Acid; Nephelometry and Turbidimetry; Norfloxacin; Urinary Tract Infections | 1984 |
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Humans; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Blood Proteins; Body Fluids; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Humans; Hydrogen-Ion Concentration; Nalidixic Acid; Norfloxacin; Protein Binding; Quinolines | 1984 |
Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Kinetics; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus; Urinary Tract; Urinary Tract Infections | 1984 |
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Micrococcaceae; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Quinolines | 1984 |
Norfloxacin--a new quinolone for urinary infection.
Topics: Anti-Infective Agents, Urinary; Humans; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1984 |
Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Bacteriuria; Child; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Middle Aged; Nalidixic Acid; Norfloxacin; Time Factors; Urinary Tract Infections | 1984 |
The antimicrobial spectrum of norfloxacin.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Frequency of appearance of resistant variants to norfloxacin and nalidixic acid.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Resistance, Microbial; Mutation; Nalidixic Acid; Norfloxacin | 1984 |
The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis.
Topics: Anti-Infective Agents, Urinary; Cystitis; Drug Resistance, Microbial; Escherichia coli; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
Bactericidal effects of norfloxacin towards bacteria in urine.
Topics: Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Blood Bactericidal Activity; Enterobacteriaceae; Humans; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1984 |
Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.
Topics: Anti-Infective Agents, Urinary; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Kinetics; Nalidixic Acid; Norfloxacin | 1984 |
The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Female; Humans; Male; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas Infections; Urinary Tract Infections | 1984 |
Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Drug Tolerance; Gonorrhea; Humans; Male; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Penicillin Resistance; Penicillins; Spectinomycin; Urethritis | 1984 |
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Nalidixic Acid; Naphthyridines; Norfloxacin; Oxolinic Acid; Pseudomonas aeruginosa; Quinolines | 1984 |
Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers.
Topics: Adult; Feces; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Time Factors | 1984 |
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Drug Interactions; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
High-performance liquid chromatographic procedure for the quantitation of norfloxacin in urine, serum and tissues.
Topics: Chromatography, High Pressure Liquid; Humans; Kidney; Male; Nalidixic Acid; Norfloxacin; Prostate | 1984 |
Pharmacokinetic studies of norfloxacin in laboratory animals.
Topics: Administration, Oral; Animals; Blood Proteins; Dogs; Female; Humans; In Vitro Techniques; Injections, Subcutaneous; Intestinal Absorption; Kinetics; Macaca mulatta; Male; Mice; Nalidixic Acid; Norfloxacin; Protein Binding; Rabbits; Rats; Rats, Inbred Strains; Suspensions; Tablets; Tissue Distribution | 1984 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
The in vitro and in vivo activity of ciprofloxacin.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Topics: 4-Quinolones; Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycoplasma; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Oxytetracycline; Quinolines; Quinolones; Ureaplasma | 1984 |
Mutational resistance to 4-quinolone antibacterial agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; Humans; Mutation; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Species Specificity | 1984 |
Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Gastroenteritis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines; Salmonella; Shigella | 1984 |
In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Gardnerella vaginalis; Haemophilus; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
In vitro activity of ciprofloxacin against group JK corynebacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Dose-Response Relationship, Drug; Humans; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
In-vitro activity of norfloxacin against Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Citrobacter; Enterobacter; Enterobacteriaceae; Escherichia coli; Klebsiella; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Proteus; Pseudomonas aeruginosa; Serratia marcescens | 1984 |
Pharmacokinetics of norfloxacin in renal failure.
Topics: Anti-Infective Agents; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Uremia | 1984 |
In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
Topics: Bacteria; Bacterial Infections; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines | 1984 |
The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
Topics: Adult; Body Fluids; Enoxacin; Half-Life; Humans; Kinetics; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Tissue Distribution | 1984 |
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones; Spectinomycin | 1984 |
Distribution of ciprofloxacin in the dog prostate and various tissues.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Dogs; Hydrogen-Ion Concentration; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Quinolines; Quinolones; Tissue Distribution | 1984 |
Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Urinary Tract Infections | 1984 |
Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Topics: Anti-Infective Agents, Urinary; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1984 |
Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Diabetes Mellitus, Experimental; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Gentamicins; Mice; Nalidixic Acid; Norfloxacin; Sulfamethizole; Sulfathiazoles; Trimethoprim | 1984 |
In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Topics: Anti-Bacterial Agents; Bacteria; Diabetes Mellitus; Drug Resistance, Microbial; Glycosuria; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Nalidixic Acid; Norfloxacin; Urine | 1984 |
In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Topics: 4-Quinolones; Anti-Infective Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines; Quinolones; Species Specificity | 1984 |
In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin | 1984 |
Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Corneal Ulcer; Drug Evaluation, Preclinical; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Pseudomonas Infections; Rabbits | 1984 |
In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Culture Media; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1980 |
Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Mice; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Urinary Tract Infections | 1981 |
Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Topics: Administration, Topical; Animals; Burns; Drug Resistance, Microbial; Female; In Vitro Techniques; Mice; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Salts; Silver; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1981 |
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; beta-Lactamases; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones | 1981 |
Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Enterobacteriaceae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1982 |
Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; DNA Damage; DNA Repair; DNA, Bacterial; Escherichia coli; Mutation; Nalidixic Acid; Norfloxacin; Ofloxacin; RNA, Bacterial; SOS Response, Genetics | 1993 |
Interference of ofloxacin with determination of urinary porphyrins.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; False Positive Reactions; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Porphyrins; Spectrometry, Fluorescence | 1994 |
Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Injections, Intravenous; Male; Nalidixic Acid; Norfloxacin; Ofloxacin; Rats; Rats, Wistar | 1994 |
Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Topics: Aminocoumarins; Anti-Infective Agents; Ciprofloxacin; Coumarins; DNA Topoisomerases, Type II; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Rifampin | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
False-positive EMIT II opiates from ofloxacin.
Topics: Anti-Infective Agents; Antibodies; Ciprofloxacin; Cross Reactions; Enzyme Multiplied Immunoassay Technique; False Positive Reactions; Humans; Morphine; Nalidixic Acid; Norfloxacin; Ofloxacin | 1997 |
Susceptibility of Pseudomonas aeruginosa of various pyocin types to the newly synthesized ampicillin derivative, N-(6,7-difluoroquinolonyl)ampicillin.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Drug Resistance, Microbial; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillins; Pseudomonas aeruginosa; Pyocins | 1997 |
Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Blastocystis hominis; Blastocystis Infections; Chloramphenicol Resistance; Ciprofloxacin; Cryptosporidiosis; Diarrhea; Dientamoebiasis; Dysentery, Amebic; Egypt; Entamoeba; Entamoeba histolytica; Escherichia coli; Escherichia coli Infections; Eukaryota; Fimbriae Proteins; Humans; Military Personnel; Nalidixic Acid; Norfloxacin; Pili, Sex; Protozoan Infections; Tetracycline Resistance; United States | 1997 |
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine; Urinary Tract Infections | 1997 |
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Furazolidone; Gentamicins; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; O Antigens; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
In vitro study of cytotoxicity of quinolones on rabbit tenocytes.
Topics: Animals; Anti-Infective Agents; Cell Survival; Cells, Cultured; Collagen; Decorin; Extracellular Matrix Proteins; Mitochondria; Nalidixic Acid; Norfloxacin; Pefloxacin; Proteoglycans; Rabbits; Succinate Dehydrogenase; Tendons | 1998 |
Photocleavage of DNA by the fluoroquinolone antibacterials.
Topics: Anti-Infective Agents; DNA Damage; Enoxacin; Fleroxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Photolysis; Plasmids; Quinolones; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
Novel action of quinolones on osteoclast-like cells.
Topics: Animals; Cells, Cultured; Dinoprostone; Histocytochemistry; Male; Mice; Nalidixic Acid; Norfloxacin; Ofloxacin; Osteoclasts; Quinolones; Spleen; Tumor Necrosis Factor-alpha | 1999 |
Promoter discrimination by the related transcriptional activators MarA and SoxS: differential regulation by differential binding.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Binding Sites; DNA-Binding Proteins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Isopropyl Thiogalactoside; Methylphenazonium Methosulfate; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Norfloxacin; Promoter Regions, Genetic; Substrate Specificity; Superoxides; Trans-Activators; Transcription Factors; Vitamin K | 2000 |
Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.
Topics: Anti-Infective Agents; Chromosomes, Bacterial; Ciprofloxacin; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Kinetics; Macromolecular Substances; Nalidixic Acid; Norfloxacin; Staphylococcus aureus; Topoisomerase II Inhibitors | 2000 |
[Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurans; Nitrofurantoin; Norfloxacin; Trimethoprim; Urinary Tract Infections | 2000 |
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cecum; Chickens; Drug Resistance, Microbial; Erythromycin; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Penicillins; Poultry Diseases; Tetracycline | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Netilmicin; Norfloxacin; Prevalence; Time Factors | 2002 |
Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.
Topics: Anti-Infective Agents; beta-Lactamases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Drug Interactions; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Porins | 2002 |
Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Vibrio cholerae O1; Vibrio cholerae O139 | 2002 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
Acquisition of quinolone resistance and point mutation of the gyrA gene in Campylobacter jejuni isolated from broilers and in vitro-induced resistant strains.
Topics: Animals; Base Sequence; Campylobacter jejuni; Chickens; DNA Gyrase; DNA Primers; Drug Resistance, Bacterial; Electrophoresis, Agar Gel; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Quinolines; Sequence Analysis, DNA | 2004 |
Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Inpatients; Microbial Sensitivity Tests; Morganella morganii; Nalidixic Acid; Norfloxacin; Salicylates; Tetracycline; Urine | 2004 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
Effects of pH and cationic and nonionic surfactants on the adsorption of pharmaceuticals to a natural aquifer material.
Topics: Acetaminophen; Adsorption; Carbamazepine; Cations; Cetylpyridinium; Environmental Monitoring; Geologic Sediments; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Nalidixic Acid; Norfloxacin; Pharmaceutical Preparations; Poloxalene; Surface-Active Agents; Water Pollution, Chemical | 2005 |
The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Topics: Anti-Bacterial Agents; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Industry; Drug Stability; Fluoroquinolones; Hydrogen-Ion Concentration; Models, Chemical; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Reproducibility of Results; Tablets; Time Factors | 2005 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Sorption of acetaminophen, 17alpha-ethynyl estradiol, nalidixic acid, and norfloxacin to silica, alumina. and a hydrophobic medium.
Topics: Acetaminophen; Adsorption; Aluminum Oxide; Analgesics, Non-Narcotic; Anti-Infective Agents; Bioreactors; Estrogens; Ethinyl Estradiol; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Nalidixic Acid; Norfloxacin; Silicon Dioxide | 2006 |
Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
Topics: 2-Acetylaminofluorene; Animals; Anti-Infective Agents; Carbon Tetrachloride; Carcinogens; Ciprofloxacin; Glutathione Transferase; Liver; Male; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred F344 | 2006 |
Fluoroquinolone resistance of Serratia marcescens: sucrose, salicylate, temperature, and pH induction of phenotypic resistance.
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Proton Pumps; Salicylates; Serratia marcescens; Sucrose; Temperature | 2007 |
Quinolone-resistant Escherichia coli.
Topics: Anti-Infective Agents; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli; Female; Genes, Bacterial; Humans; Male; Mutation; Nalidixic Acid; Norfloxacin | 2008 |
An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Membrane Transport Proteins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinazolines | 2011 |
The ferritin-like protein Dps protects Salmonella enterica serotype Enteritidis from the Fenton-mediated killing mechanism of bactericidal antibiotics.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Bacterial Proteins; DNA-Binding Proteins; Drug Resistance, Bacterial; Ferritins; Hydrogen Peroxide; Hydroxyl Radical; Iron; Nalidixic Acid; Norfloxacin; Oxidative Stress; Rec A Recombinases; Rifampin; Salmonella enteritidis; Sequence Deletion; Streptomycin | 2011 |
[Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Frequency; Genes, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Poland; Species Specificity | 2012 |
Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plankton; Proteus mirabilis; Quinolones | 2013 |
[Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Breaks, Double-Stranded; DNA Helicases; DNA Repair; DNA Replication; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Exodeoxyribonuclease V; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Targeted Therapy; Nalidixic Acid; Norfloxacin; Quinolones; Rec A Recombinases; Recombinational DNA Repair; Serine Endopeptidases; SOS Response, Genetics | 2015 |
Quinolone Resistance Determinants of Clinical Salmonella Enteritidis in Thailand.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clone Cells; DNA Gyrase; Drug Resistance, Bacterial; Gene Expression; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Nalidixic Acid; Norfloxacin; Phylogeny; Plasmids; Prevalence; Salmonella enteritidis; Salmonella Infections; Thailand | 2017 |
First report of the qnrA determinant in Shigella sonnei isolated from China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Drug Resistance, Bacterial; Nalidixic Acid; Norfloxacin; Shigella sonnei | 2017 |
Genetic diversity of Salmonella enterica recovered from chickens farms and its potential transmission to human.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Chickens; Colistin; Fluoroquinolones; Genetic Variation; Gentamicins; Humans; Nalidixic Acid; Norfloxacin; Penicillins; Phylogeny; Polymerase Chain Reaction; Poultry Diseases; Salmonella enterica; Salmonella Infections, Animal; Sequence Alignment; Sequence Analysis, DNA; Zoonoses | 2020 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |